Frederick L. Locke, Javier L. Munoz, Michael T. Tees, Lazaros J. Lekakis, Sven de Vos, Rajneesh Nath, Don A. Stevens, Shahbaz A. Malik, Geoffrey P. Shouse, Mehdi Hamadani, Olalekan O. Oluwole, Miguel-Angel Perales, David B. Miklos, Paul W. Fisher, Amy Feng, Lynn Navale, John B. Le Gall, Sattva S. Neelapu. "Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies." Journal of Clinical Oncology, 2025. doi:10.1200/jco-24-01933